Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Establishing FDA-approved oncology drugs as GPR176 inhibitor through homology modelling, molecular docking, MMGBSA, DFT, and molecular dynamics simulation

2026Scientific ReportsJournalOpen access

10.1038/s41598-025-31607-9 Full text2 citations

Authors

12 authors across 13 institutions in 8 countries.

Felix Oluwasegun IshabiyiFirst authorCorresponding
- University of Lagos (NG)
- University of Ibadan (NG)
Haruna Isiyaku UmarCorresponding
- Federal University of Technology (NG)
Tanmoy Dutta
Okoyenta Celestina Onyinye
- Nigerian Institute of Medical Research (NG)
Olusola Daniel Damola
- Kwara State University (NG)
Leyla Budagova
Denekew TemesgenCorresponding
- Bahir Dar University (ET)
Mohammed Bourhia
Ridwan O. Bello
as printed: Ridwan Opeyemi Bello
Esmael M. Alyami
Mona Alsolami
Omar A. AlmohammedSenior author

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Receptor Mechanisms and Signalinglevel 3 · 0.66
Diabetes Treatment and Managementlevel 3 · 0.05
Protein Degradation and Inhibitorslevel 3 · 0.03

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 10, 2026
2026 · Scientific Reports · 2 citations
https://openalex.org/W7118071757

Establishing FDA-approved oncology drugs as GPR176 inhibitor through homology modelling, molecular docking, MMGBSA, DFT, and molecular dynamics simulation · Sankore